Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > MPL Q3 & Onward
View:
Post by CADInvestor12 on Oct 29, 2024 1:48pm

MPL Q3 & Onward

Fingers crossed that Q3 earnings continue to build off Q1 & Q2 momentum ... would be nice if they comment on US rescheduling, at a high level rescheduling will allow them to compete in US market (Dronabinol/ Sativex/ Marinol all currently derived synthetically) + who knows what other opps they are working on ... wish this came from management but it looks like the Brazil partner (or 1 of) is Active Pharmaceutca Ltd, acquired by Caldic .. can't find much info on them ... see on page 6 of link below:

https://www.gov.br/anvisa/pt-br/composicao/diretoria-colegiada/reunioes-da-diretoria/extratos-dos-circuitos-deliberativos-1/2023/extrato-cd-1003-2023-2013-cronograma-de-inspecao-25351-9271762023-56.pdf/@@download/file
Comment by CADInvestor12 on Oct 29, 2024 1:58pm
https://magistralbr.caldic.com/canabidiol
Comment by QContinuum1 on Oct 29, 2024 2:59pm
Can't tell if the play through Caldic is API or finished product.  Active Pharma certainly read like an API play. That said: "Cannabidiol Active Pharmaceutica 20 mg/mL is manufactured in Canada, by a company qualified by Caldic in accordance with the requirements of the regulatory agency, ANVISA. The product is subjected to quality control laboratory analyses, thus allowing the ...more  
Comment by CADInvestor12 on Oct 29, 2024 3:21pm
It looks like finished product https://magistralbr.caldic.com/images/1788255779.pdf#page167  
Comment by Lemoyne on Oct 29, 2024 3:25pm
If you go on consultas anvisa, you can see it's a 30ml format, hence finished product.
Comment by QContinuum1 on Oct 29, 2024 3:40pm
This is all really good stuff.  Thanks for this.  A welcome change to the normal background hum.
Comment by alleyesonme on Oct 29, 2024 7:19pm
Thank you!. Great job!...https://www.grandviewresearch.com/horizon/outlook/cannabis-pharmaceuticals-market/brazil
Comment by QContinuum1 on Oct 29, 2024 2:57pm
About Caldic Caldic is a full-service solution provider engaged in the development of specialty solutions in the food, health & personal care and industrial markets. With locations throughout Europe, North America and Asia-Pacific, its strengths lie in its global network combined with local expertise, giving the flexibility to answer local needs and build domestic partnerships. Operating with ...more  
Comment by okgonow on Oct 29, 2024 3:55pm
thanks nice diggin!!!! well done now this is excellent news they are close in Brazil
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities